Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunopathogenesis of SLE

L J Mason1, D A Isenberg

  • 1Bloomsbury Rheumatology Unit, Department of Medicine, University College London, UK.

Bailliere'S Clinical Rheumatology
|January 16, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013
Same author

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013
Same author

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013
Same author

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013
Same author

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012
Same author

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012
Same journal

Regional soft tissue pains: alias myofascial pain?

Bailliere's clinical rheumatology·1999
Same journal

The knee

Bailliere's clinical rheumatology·1999
Same journal

The elbow, forearm, wrist and hand

Bailliere's clinical rheumatology·1999
Same journal

Shoulder disorders: a state-of-the-art review

Bailliere's clinical rheumatology·1999
Same journal

The neck

Bailliere's clinical rheumatology·1999
Same journal

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
See all related articles

Systemic lupus erythematosus (SLE) involves environmental factors and genetic susceptibility, leading to immune system dysregulation. Research explores how autoantigens and tolerance breakdown generate pathogenic autoantibodies in SLE patients.

Area of Science:

  • Rheumatology and Immunology
  • Autoimmune Disease Pathogenesis

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease defined by autoantibody and immune complex deposition, causing tissue damage.
  • The precise immunopathogenesis of SLE remains incompletely understood, suggesting a complex interplay of genetic and environmental factors.
  • A failure in immune system regulation allows abnormal responses, including B cell activation and T cell hyperactivity, in susceptible individuals.

Purpose of the Study:

  • To elucidate the mechanisms underlying autoantigen availability and the breakdown of self-tolerance in SLE.
  • To investigate the origins of pathogenic autoantibodies central to SLE development.
  • To explore the roles of key molecular players in SLE pathogenesis.

Main Methods:

  • Review of current research on the immunopathogenesis of SLE.

Related Experiment Videos

  • Analysis of factors contributing to autoantigen presentation and immune tolerance failure.
  • Investigation into the involvement of cytokines, adhesion molecules, co-stimulatory molecules, and apoptosis.

    • Main Results:

    • Environmental agents interacting with susceptibility genes are implicated as initial triggers in predisposed individuals.
    • Breakdown of immune tolerance and polyclonal B cell activation are critical events in SLE.
    • Ongoing research focuses on identifying specific molecular pathways and mediators.

    Conclusions:

    • Understanding the intricate puzzle of SLE immunopathogenesis requires further investigation into autoantigen availability and tolerance mechanisms.
    • Cytokines, adhesion molecules, co-stimulatory molecules, and apoptosis are key areas for future research in SLE.
    • Identifying these missing pieces is crucial for developing effective therapeutic strategies for systemic lupus erythematosus.